ATC
BSX icon

Argent Trust Co’s Boston Scientific BSX Stock Holding History

Argent Trust Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$962K Sell
15,336
-219
-1% -$17.5K 0.03% 354
2025
Q4 		$1.48M Sell
15,555
-2,304
-13% -$226K 0.05% 279
2025
Q3 		$1.74M Buy
17,859
+925
+5% +$95.8K 0.06% 258
2025
Q2 		$1.82M Sell
16,934
-966
-5% -$97.7K 0.07% 244
2025
Q1 		$1.81M Buy
17,900
+63
+0.4% +$6.34K 0.07% 232
2024
Q4 		$1.59M Sell
17,837
-663
-4% -$58.4K 0.07% 248
2024
Q3 		$1.55M Sell
18,500
-1,000
-5% -$78.8K 0.06% 249
2024
Q2 		$1.5M Buy
19,500
+753
+4% +$55.1K 0.07% 247
2024
Q1 		$1.28M Buy
18,747
+11,492
+158% +$739K 0.06% 270
2023
Q4 		$419K Hold
7,255
– – 0.02% 432
2023
Q3 		$383K Buy
7,255
+700
+11% +$36.7K 0.02% 436
2023
Q2 		$355K Buy
6,555
+1,800
+38% +$94K 0.02% 455
2023
Q1 		$238K Buy
4,755
+138
+3% +$6.5K 0.02% 471
2022
Q4 		$214K Buy
+4,617
New +$200K 0.01% 488
2022
Q2 		– Sell
-4,991
Closed -$222K – 516
2022
Q1 		$222K Hold
4,991
– – 0.01% 507
2021
Q4 		$212K Sell
4,991
-550
-10% -$23.1K 0.01% 523
2021
Q3 		$240K Sell
5,541
-44
-0.8% -$1.95K 0.02% 479
2021
Q2 		$239K Buy
+5,585
New +$235K 0.02% 470
2020
Q4 		– Sell
-5,343
Closed -$204K – 465
2020
Q3 		$204K Sell
5,343
-480
-8% -$18.5K 0.02% 435
2020
Q2 		$205K Sell
5,823
-16,578
-74% -$597K 0.02% 425
2020
Q1 		$731K Buy
22,401
+52
+0.2% +$2.03K 0.08% 208
2019
Q4 		$1.01M Buy
22,349
+59
+0.3% +$2.47K 0.09% 204
2019
Q3 		$906K Buy
+22,290
New +$944K 0.09% 210

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Argent Trust Co's BSX Position: Q1 2026 in Review

Argent Trust Co reduced its Boston Scientific (BSX) stake by 1.4% in Q1 2026, selling an estimated $17.5K and leaving 15,336 shares worth $962K. The position accounts for 0.03% of the portfolio, ranked #354.

Argent Trust Co first reported a position in BSX in Q3 2019 and has held it in 23 quarters since. The position peaked at $1.82M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Argent Trust Co held 15,336 shares of Boston Scientific worth $962K as of Q1 2026.
  • Argent Trust Co sold 219 Boston Scientific shares in Q1 2026, an estimated $17.5K.
  • Boston Scientific made up 0.03% of Argent Trust Co's portfolio in Q1 2026, its #354 holding.
  • Argent Trust Co first reported a position in Boston Scientific in Q3 2019 and has held it in 23 quarters since.
  • Argent Trust Co's Boston Scientific position peaked at $1.82M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.